Evidence map›Paper›PMID 35194685›Full record

ArticleMycorrhiza2022

Quercetin and 1-methyl-2-oxindole mimic root signaling that promotes spore germination and mycelial growth of Gigaspora margarita.

Alberto Campos-López, Jaime A Uribe-López, Verna Cázares-Ordoñez, Roberto Garibay-Orijel, Norma A Valdez-Cruz, Mauricio A Trujillo-Roldán

Abstract read
PubMed Publisher
In one paragraph

Article in Mycorrhiza, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Alberto Campos-López *Programa de Investigación de Producción de Biomoléculas, Departamento de Biología Molecular and Biotecnología, Unidad de Bioprocesos, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México. AP. 70228, México D.F., CP. 04510. Av. Universidad 3000, Cd. Universitaria, Coyoacán, 04510, Ciudad de México, México.
Jaime A Uribe-López *Programa de Investigación de Producción de Biomoléculas, Departamento de Biología Molecular and Biotecnología, Unidad de Bioprocesos, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México. AP. 70228, México D.F., CP. 04510. Av. Universidad 3000, Cd. Universitaria, Coyoacán, 04510, Ciudad de México, México.
Verna Cázares-OrdoñezPrograma de Investigación de Producción de Biomoléculas, Departamento de Biología Molecular and Biotecnología, Unidad de Bioprocesos, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México. AP. 70228, México D.F., CP. 04510. Av. Universidad 3000, Cd. Universitaria, Coyoacán, 04510, Ciudad de México, México.
Roberto Garibay-OrijelInstituto de Biología, Universidad Nacional Autónoma de México. Av. Universidad, 3000, Cd. Universitaria, Coyoacán, 04510, Ciudad de México, México.ORCID http://orcid.org/0000-0002-6977-7550
Norma A Valdez-CruzPrograma de Investigación de Producción de Biomoléculas, Departamento de Biología Molecular and Biotecnología, Unidad de Bioprocesos, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México. AP. 70228, México D.F., CP. 04510. Av. Universidad 3000, Cd. Universitaria, Coyoacán, 04510, Ciudad de México, México.ORCID http://orcid.org/0000-0002-8581-1173
Mauricio A Trujillo-RoldánPrograma de Investigación de Producción de Biomoléculas, Departamento de Biología Molecular and Biotecnología, Unidad de Bioprocesos, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México. AP. 70228, México D.F., CP. 04510. Av. Universidad 3000, Cd. Universitaria, Coyoacán, 04510, Ciudad de México, México. maurotru@gmail.com.ORCID http://orcid.org/0000-0002-7497-4452
Universidad Nacional Autónoma de México · MXColombian Corporation for Agricultural Research - AGROSAVIA · CO

Funding

Consejo Nacional de Ciencia y Tecnología 553999Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México IT-200719
6 · The paper itself

Abstract

Arbuscular mycorrhizal fungi (AMF) are obligate biotrophs, and the difficulty of growing them in asymbiotic or monoxenic (AMF + root) conditions limits research and their large-scale production as biofertilizer. We hypothesized that a combination of flavanols and strigolactones can mimic complex root signaling during the presymbiotic stages of AMF. We evaluated the germination, mycelial growth, branching, and auxiliary cell clusters formation by Gigaspora margarita during the presymbiotic stage in the presence (or absence) of transformed Cichorium intybus roots in basal culture medium enriched with glucose, a flavonol (quercetin or biochanin A) and a strigolactone analogue (1-Methyl-2-oxindole or indole propionic acid). With quercetin (5 µM), methyl oxindole (2.5 nM), and glucose (8.2 g/L) in the absence of roots, the presymbiotic mycelium of G. margarita grew without cytoplasmic retraction and produced auxiliary cells over 71 days similar to presymbiotic mycelium in the presence of roots but without glucose, strigolactones, and flavonols. Our results indicate that glucose and a specific combination of certain concentrations of a flavonol and a strigolactone might be used in asymbiotic or monoxenic liquid or semisolid cultures to stimulate AMF inoculant bioprocesses.

Indexed as

MycorrhizaePlant RootsQuercetinFungiGerminationMyceliumOxindolesSporesSymbiosis2-oxindoleOxindolesQuercetinArbuscular mycorrhizal fungi (AMF)Cichorium intybusCultivation gradientGigaspora margaritaRoot signalingTransformed root cultures

Identifiers

PMID35194685
OpenAlexW4213452436

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.